Encompass Health Corporation
EHC · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $9 | $7 | $6 | $5 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $3 | $3 | $3 | $4 |
| Enterprise Value | $12 | $10 | $9 | $9 |
| Revenue | $5 | $5 | $4 | $4 |
| % Growth | 11.9% | 10.4% | 8.3% | – |
| Gross Profit | $2 | $2 | $2 | $2 |
| % Margin | 41.6% | 41.3% | 40.3% | 42.4% |
| EBITDA | $1 | $1 | $1 | $1 |
| % Margin | 22.1% | 20.9% | 20% | 22.1% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 8.5% | 7.3% | 6.2% | 10.3% |
| EPS Diluted | 4.46 | 3.47 | 2.7 | 4.11 |
| % Growth | 28.5% | 28.5% | -34.3% | – |
| Operating Cash Flow | $1 | $1 | $1 | $1 |
| Capital Expenditures | -$1 | -$1 | -$1 | -$1 |
| Free Cash Flow | $0 | $0 | $0 | $0 |